These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8003514)
1. Crosstalk between domains in the regulatory subunit of cAMP-dependent protein kinase: influence of amino terminus on cAMP binding and holoenzyme formation. Herberg FW; Dostmann WR; Zorn M; Davis SJ; Taylor SS Biochemistry; 1994 Jun; 33(23):7485-94. PubMed ID: 8003514 [TBL] [Abstract][Full Text] [Related]
2. Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase. Herberg FW; Taylor SS; Dostmann WR Biochemistry; 1996 Mar; 35(9):2934-42. PubMed ID: 8608131 [TBL] [Abstract][Full Text] [Related]
3. Dissecting the domain structure of the regulatory subunit of cAMP-dependent protein kinase I and elucidating the role of MgATP. Ringheim GE; Taylor SS J Biol Chem; 1990 Mar; 265(9):4800-8. PubMed ID: 2156855 [TBL] [Abstract][Full Text] [Related]
4. Role of MgATP in the activation and reassociation of cAMP-dependent protein kinase I: consequences of replacing the essential arginine in cAMP binding site A. Neitzel JJ; Dostmann WR; Taylor SS Biochemistry; 1991 Jan; 30(3):733-9. PubMed ID: 1846304 [TBL] [Abstract][Full Text] [Related]
5. cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP. Zawadzki KM; Taylor SS J Biol Chem; 2004 Feb; 279(8):7029-36. PubMed ID: 14625280 [TBL] [Abstract][Full Text] [Related]
6. Human regulatory subunit RI beta of cAMP-dependent protein kinases: expression, holoenzyme formation and microinjection into living cells. Solberg R; Taskén K; Wen W; Coghlan VM; Meinkoth JL; Scott JD; Jahnsen T; Taylor SS Exp Cell Res; 1994 Oct; 214(2):595-605. PubMed ID: 7925653 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the isolated cAMP-binding B domain of cAMP-dependent protein kinase. Shabb JB; Poteet CE; Kapphahn MA; Muhonen WM; Baker NE; Corbin JD Protein Sci; 1995 Oct; 4(10):2100-6. PubMed ID: 8535246 [TBL] [Abstract][Full Text] [Related]
8. Mutations in the autoinhibitor site of the regulatory subunit of cAMP-dependent protein kinase I. Replacement of Ala-97 and Ser-99 interferes with reassociation with the catalytic subunit. Buechler YJ; Taylor SS J Biol Chem; 1991 Feb; 266(6):3491-7. PubMed ID: 1847375 [TBL] [Abstract][Full Text] [Related]
9. Holoenzyme interaction sites in the cAMP-dependent protein kinase. Histidine 87 in the catalytic subunit complements serine 99 in the type I regulatory subunit. Cox S; Taylor SS J Biol Chem; 1994 Sep; 269(36):22614-22. PubMed ID: 8077212 [TBL] [Abstract][Full Text] [Related]
10. A point mutation abolishes binding of cAMP to site A in the regulatory subunit of cAMP-dependent protein kinase. Bubis J; Neitzel JJ; Saraswat LD; Taylor SS J Biol Chem; 1988 Jul; 263(20):9668-73. PubMed ID: 2898473 [TBL] [Abstract][Full Text] [Related]
11. Physiological inhibitors of the catalytic subunit of cAMP-dependent protein kinase: effect of MgATP on protein-protein interactions. Herberg FW; Taylor SS Biochemistry; 1993 Dec; 32(50):14015-22. PubMed ID: 8268180 [TBL] [Abstract][Full Text] [Related]
12. Contribution of the carboxyl-terminal regional of the cAMP-dependent protein kinase type I alpha regulatory subunit to cyclic nucleotide interactions. Kapphahn MA; Shabb JB Arch Biochem Biophys; 1997 Dec; 348(2):347-56. PubMed ID: 9434747 [TBL] [Abstract][Full Text] [Related]
13. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS). Hamuro Y; Anand GS; Kim JS; Juliano C; Stranz DD; Taylor SS; Woods VL J Mol Biol; 2004 Jul; 340(5):1185-96. PubMed ID: 15236976 [TBL] [Abstract][Full Text] [Related]
14. Recombinant strategies for rapid purification of catalytic subunits of cAMP-dependent protein kinase. Hemmer W; McGlone M; Taylor SS Anal Biochem; 1997 Feb; 245(2):115-22. PubMed ID: 9056191 [TBL] [Abstract][Full Text] [Related]
15. Expression of a chimeric, cGMP-sensitive regulatory subunit of the cAMP-dependent protein kinase type I alpha. Wild N; Herberg FW; Hofmann F; Dostmann WR FEBS Lett; 1995 Nov; 374(3):356-62. PubMed ID: 7589570 [TBL] [Abstract][Full Text] [Related]
16. Ala335 is essential for high-affinity cAMP-binding of both sites A and B of cAMP-dependent protein kinase type I. Zorn M; Fladmark KE; Ogreid D; Jastorff B; Døskeland SO; Dostmann WR FEBS Lett; 1995 Apr; 362(3):291-4. PubMed ID: 7729515 [TBL] [Abstract][Full Text] [Related]
17. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation. Kim C; Cheng CY; Saldanha SA; Taylor SS Cell; 2007 Sep; 130(6):1032-43. PubMed ID: 17889648 [TBL] [Abstract][Full Text] [Related]
18. A constitutively active holoenzyme form of the cAMP-dependent protein kinase. Wang YH; Scott JD; McKnight GS; Krebs EG Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2446-50. PubMed ID: 1848703 [TBL] [Abstract][Full Text] [Related]
19. The conformationally dynamic C helix of the RIalpha subunit of protein kinase A mediates isoform-specific domain reorganization upon C subunit binding. Vigil D; Blumenthal DK; Taylor SS; Trewhella J J Biol Chem; 2005 Oct; 280(42):35521-7. PubMed ID: 16109722 [TBL] [Abstract][Full Text] [Related]
20. Cyclic-AMP and pseudosubstrate effects on type-I A-kinase regulatory and catalytic subunit binding kinetics. Anand G; Taylor SS; Johnson DA Biochemistry; 2007 Aug; 46(32):9283-91. PubMed ID: 17658893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]